• Tuesday, Dec 06, 2022
  • Last Update : 10:24 am
US gives full approval to antiviral...

Covid-19: US fully approves...

North America

Fri, Oct 23 2020

Gilead has set the price at $390 per vial in developed countries, or $2,340 for six vials used over the...

Gilead nears deal to buy Immunomedics...

Gilead nears deal to buy...

North America

Sun, Sep 13 2020

An acquisition of Immunomedics would add to several deals Gilead inked this year with the aim of expanding...

Gilead analysis shows remdesivir reduced...

Gilead analysis shows remdesivir reduced...

Coronavirus

Sat, Jul 11 2020

The US government trial in April showed that patients given remdesivir recovered 31% faster than those...

Gilead's remdesivir set to become Europe's...

Gilead's remdesivir set to become Europe's...

Europe

Thu, Jun 25 2020

Physicians can prescribe the drug in Europe once the European Commission gives its approval

Gilead's remdesivir shows improvement...

Gilead's remdesivir shows improvement...

World

Tue, Jun 2 2020

Around 70% of patients who received remdesivir for 10 days showed improvement

Roche, Gilead to test drug cocktail...

Roche, Gilead to test drug cocktail...

World

Sat, May 30 2020

The clinical trial is due to begin in early June with approximately 450 patients participating